AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. ASKA pharmaceutical Co., Ltd.
  3. Financials
  4. Retained earnings

ASKA pharmaceutical Co., Ltd.【JP:E00929】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Mar 31, 202039,560-2.63%
Mar 31, 201940,630+3.44%
Mar 31, 201839,280+5.27%
Mar 31, 201737,312+7.34%
Mar 31, 201634,759+0.91%
Mar 31, 201534,447

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)